Stephens & Co. initiated coverage on Anika Therapeutics with a new price target
$ANIK
Medical/Dental Instruments
Health Care
Stephens & Co. initiated coverage of Anika Therapeutics with a rating of Overweight and set a new price target of $55.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/17/2025 | $21.00 | Buy | B. Riley Securities |
| 11/1/2024 | $37.00 → $25.00 | Outperform | Barrington Research |
| 8/14/2023 | $24.00 | Mkt Perform → Outperform | Barrington Research |
| 3/7/2023 | Outperform → Mkt Perform | Barrington Research | |
| 11/9/2022 | $31.00 | Mkt Perform → Outperform | Barrington Research |
| 10/14/2022 | $26.00 | Equal-Weight | Stephens |
| 3/9/2022 | Outperform → Mkt Perform | Barrington Research | |
| 3/9/2022 | Overweight → Equal-Weight | Stephens & Co. |
B. Riley Securities initiated coverage of Anika Therapeutics with a rating of Buy and set a new price target of $21.00
Barrington Research reiterated coverage of Anika Therapeutics with a rating of Outperform and set a new price target of $25.00 from $37.00 previously
Barrington Research upgraded Anika Therapeutics from Mkt Perform to Outperform and set a new price target of $24.00